mouse anti mouse cd45 1 fitc (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
92
Structured Review
Miltenyi Biotec
mouse anti mouse cd45 1 fitc
Mouse Anti Mouse Cd45 1 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 297 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+mouse+cd45+1+fitc/CD45%2E1+Antibody%2C+anti-mouse/pmc12744263__BLOODA_ADV___2024___012639___mmc1-1-44-48
Average 92 stars, based on 297 article reviews
Mouse Anti Mouse Cd45 1 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 297 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti+mouse+cd45+1+fitc/CD45%2E1+Antibody%2C+anti-mouse/pmc12744263__BLOODA_ADV___2024___012639___mmc1-1-44-48
Average 92 stars, based on 297 article reviews
mouse anti mouse cd45 1 fitc - by Bioz Stars,
2026-09
92/100 stars
Images
Related Articles
Virus:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Recombinant:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Enzyme-linked Immunosorbent Assay:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Binding Assay:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Staining:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Modification:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Saline:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Concentration Assay:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Over Expression:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Protein Extraction:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Membrane:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), SYBR Green Assay:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Bicinchoninic Acid Protein Assay:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Protease Inhibitor:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), CCK-8 Assay:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Reverse Transcription:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Selection:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Plasmid Preparation:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Knock-Out:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Software:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Real-time Polymerase Chain Reaction:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), Flow Cytometry:Article Title: Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells Article Snippet: Article Title: Androgen receptor signaling as a new target for intervention in acute myeloid leukemia Article Snippet: Florescent antibodies: Rat anti-mouse Ly-6A/E (Sca-1) (PE-CyTM7) (BD PharmingenTM 558162), Rat anti-mouse CD117 (c-kit) (APC) (BioLegend 105812), Mouse anti-human/mouse Phospho-S6 (Ser235, Ser236) (cupk43k) (APC) (eBioscienceTM 17-9007-42), Mouse anti-human/mouse Phospho-4EBP1 (Thr36, Thr45) (V3NTY24) (eFluor 660) (eBioscienceTM 50-9107-42), PE-Annexin V (BD Pharmingen 51-65875X),7-AAD (BD Pharmingen 51-68981E), |
